Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

17
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
17
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

6
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
6
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

17
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
17
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

17
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
17
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

21
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
21
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

18
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
18

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Routine admission biomarkers for identifying co-infection and stratifying severity in pediatric macrolide-resistant <i>Mycoplasma pneumoniae</i> pneumonia: a retrospective cohort study.

Translational pediatrics·2026
Same author

Regulatory Effects of the PDE8B Inhibitor PF-04957325 on Cognitive Impairment and Neuroinflammation in Aβ-Induced Alzheimer's Disease Mouse Models.

Neurochemical research·2026
Same author

The "DeepSeek effect" and the adoption-integration gap of generative artificial intelligence in clinical practice: a national online convenience cross-sectional survey of academic critical care physicians in China.

Frontiers in medicine·2026
Same author

Cancer Heterogeneity and Cancer Cell Plasticity: Molecular Mechanisms and Precision Therapy.

MedComm·2026
Same author

Effect of Tongxie Yaofang formula on the gut microbiota of diarrhea model mice: a combined strategy of network pharmacology, molecular docking, and 16S rRNA gene sequencing.

Bioscience of microbiota, food and health·2026
Same author

Toward sustainable aesthetic education: exploring the impact of GenAl collaboration on students' critical thinking disposition.

Frontiers in psychology·2026

関連する実験動画

Updated: Feb 17, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.7K

特定のイオン共活性化効果によって誘発されるトランジントポリマーマイクロカプセルからのプログラム可能なペイロードの放出

Shijia Tang1, Liuyan Tang1, Xiaocun Lu1

  • 1Beckman Institute for Advanced Science and Technology, ‡Department of Materials Science and Engineering, and ∥Department of Chemistry, University of Illinois at Urbana-Champaign , Urbana, Illinois 61801, United States.

Journal of the American Chemical Society
|December 13, 2017
PubMed
まとめ

研究者は,一時的なポリマーの特定のイオン共活性化 (SICA) 効果を発見しました. この発見により,特定のイオン組合せを用いた制御されたペイロードの放出のためのプログラム可能なマイクロカプセルの開発が可能になる.

さらに関連する動画

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.3K
Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release
08:39

Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release

Published on: July 4, 2017

9.5K

関連する実験動画

Last Updated: Feb 17, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.7K
Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.3K
Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release
08:39

Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release

Published on: July 4, 2017

9.5K

科学分野:

  • 材料科学
  • ポリマー化学
  • 超分子化学

背景:

  • 刺激に反応する材料は化学的な論理ゲートと信号増幅に不可欠です.
  • 材料における共活性化反応の特徴づけは依然として課題である.

研究 の 目的:

  • 臨時ポリマー固体における特定のイオン共活性化 (SICA) 効果を証明し,特徴づけること.
  • SICA効果に基づいてプログラム可能なマイクロカプセルを開発する.

主な方法:

  • 各種イオンを含む酸性メタノール溶液中の循環型ポリフタアルデヒド (cPPA) コアシェルマイクロカプセルの脱ポリメリゼーションを調査した.
  • 脱ポリマー化率に対するアニオンとカチオンの影響を分析し,それをホフマイスターの行動と相関させた.

主要な成果:

  • cPPAのデポリメリゼーションの有意な加速は,酸と特定のイオンによる同活性化で観察されました.
  • SICA効果は主にアニオンによって制御され,カチオンは二次的な調節作用をします.
  • 塩と酸性メタノール溶液の組成に依存するプログラム可能なペイロード放出率を持つcPPAマイクロカプセルを開発しました.

結論:

  • SICA効果は,一時的なポリマーの分解を制御するための新しいメカニズムを提供します.
  • この研究は,高度な反応性のある材料とスマートな配送システムの設計のための基盤を確立します.